Railroad Therapeutics: what changed
Railroad Therapeutics
Largest movements
- Cash +€458,403
up €458,403 (+640%), from €71,585 to €529,988
mainly Contributions, distributions and other (+€621,504) and Accrued charges and deferred income (+€147,778)
- Receivables within one year +€12,826
up €12,826 (+27.3%), from €47,056 to €59,882
of which Other amounts receivable: +€9,053
- Contributions +€621,504
up €621,504 (+4,143%), from €15,000 to €636,504
- Debts after one year -€190,000
no longer reported in 2025 (was €190,000)
- Accrued charges and deferred income +€147,778
new in 2025: €147,778
- Profit (loss) carried forward -€127,809
down €127,809 (-180%), from -€70,944 to -€198,753
- Trade debts +€19,577
up €19,577 (+203%), from €9,635 to €29,212
- Gross operating margin -€101,992
down €101,992, from €73,752 to -€28,240
- Financial income +€76,418
up €76,418 (+259%), from €29,497 to €105,915
- Depreciation +€10,302
up €10,302 (+8.0%), from €129,138 to €139,439
- Financial charges +€6,559
up €6,559 (+925%), from €709 to €7,268
- Taxes +€2,515
up €2,515 (+38.0%), from -€6,618 to -€4,103
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €143,808 | €619,622 | +€475,815 | +331% |
| Fixed assets | 21/28 | €363 | €363 | = | 0.0% |
| Financial fixed assets | 28 | €363 | €363 | = | 0.0% |
| Current assets | 29/58 | €143,445 | €619,259 | +€475,815 | +332% |
| Amounts receivable after more than one year | 29 | €24,804 | €28,907 | +€4,103 | +16.5% |
| Other amounts receivable | 291 | €24,804 | €28,907 | +€4,103 | +16.5% |
| Amounts receivable within one year | 40/41 | €47,056 | €59,882 | +€12,826 | +27.3% |
| Trade receivables | 40 | €6,273 | €10,046 | +€3,774 | +60.2% |
| Other amounts receivable | 41 | €40,783 | €49,835 | +€9,053 | +22.2% |
| Cash at bank and in hand | 54/58 | €71,585 | €529,988 | +€458,403 | +640% |
| Deferred charges and accrued income | 490/1 | - | €483 | +€483 | |
| Total equity and liabilities | 10/49 | €143,808 | €619,622 | +€475,815 | +331% |
| Equity | 10/15 | -€55,944 | €437,751 | +€493,695 | |
| Contributions | 10/11 | €15,000 | €636,504 | +€621,504 | +4,143% |
| Profit (loss) carried forward | 14 | -€70,944 | -€198,753 | -€127,809 | -180% |
| Amounts payable | 17/49 | €199,752 | €181,871 | -€17,881 | -9.0% |
| Amounts payable after more than one year | 17 | €190,000 | - | -€190,000 | |
| Financial debts | 170/4 | €190,000 | - | -€190,000 | |
| Amounts payable within one year | 42/48 | €9,752 | €34,093 | +€24,341 | +250% |
| Trade debts | 44 | €9,635 | €29,212 | +€19,577 | +203% |
| Suppliers | 440/4 | €9,635 | €29,212 | +€19,577 | +203% |
| Taxes, remuneration and social security | 45 | - | €4,710 | +€4,710 | |
| Remuneration and social security | 454/9 | - | €4,710 | +€4,710 | |
| Other amounts payable | 47/48 | €117 | €171 | +€54 | +46.2% |
| Accrued charges and deferred income | 492/3 | - | €147,778 | +€147,778 | |
| Remuneration, social security and pensions | 62 | €60,883 | €62,879 | +€1,996 | +3.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €129,138 | €139,439 | +€10,302 | +8.0% |
| Gross operating margin | 9900 | €73,752 | -€28,240 | -€101,992 | |
| Operating profit (loss) | 9901 | -€116,269 | -€230,559 | -€114,290 | -98.3% |
| Financial income | 75/76B | €29,497 | €105,915 | +€76,418 | +259% |
| Recurring financial income | 75 | €29,497 | €105,915 | +€76,418 | +259% |
| Financial charges | 65/66B | €709 | €7,268 | +€6,559 | +925% |
| Recurring financial charges | 65 | €709 | €7,268 | +€6,559 | +925% |
| Profit (loss) for the period before taxes | 9903 | -€87,480 | -€131,912 | -€44,431 | -50.8% |
| Income taxes | 67/77 | -€6,618 | -€4,103 | +€2,515 | +38.0% |
| Profit (loss) for the period | 9904 | -€80,862 | -€127,809 | -€46,947 | -58.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€80,862 | -€127,809 | -€46,947 | -58.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.